Descripción de las características en prueba de esfuerzo cardiopulmonar en aptitud cardiorrespiratoria y respuesta al ejercicio de pacientes que cursaron con infección por SARS-CoV-2 leve

dc.contributor.advisorSarmiento Castaneda, Juan Manuel
dc.contributor.advisorLineros Montanez, Alberto
dc.contributor.advisorOrtiz Maluendas, Oscar Humberto
dc.contributor.advisorSarmiento, Alejandro
dc.contributor.authorCortes Rosero, Sebastian Camilo
dc.date.accessioned2024-04-03T18:44:44Z
dc.date.available2024-04-03T18:44:44Z
dc.date.issued2024-04
dc.description.abstractSe trata de una recopilación de estudios presentes en la literatura científica que describen la fisiopatología del COVID-19, el impacto de la afección cardiopulmonar propia de esta enfermedad en la aptitud cardiorrespiratoria y capacidad de ejercicio en este grupo de pacientes y una descripción detallada de la evaluación holística e integrativa que la prueba de esfuerzo cardiopulmonar puede otorgar de la función cardiopulmonar en esfuerzo de los pacientes recuperados de infección por SARS-CoV-2, denotando los hallazgos esperables o más frecuentes en las pruebas realizadas en esta población. Destacamos que, incluso en los pacientes que cursaron con COVID-19 leve, la función cardiorrespiratoria expresada en su variable insignia: captación de oxígeno (VO2), se encuentra generalmente reducida, aunque dicha reducción suele ser mayor con forma mayor haya sido la severidad del cuadro agudo. Se ha evidenciado también que dicha reducción puede ser influenciada por ineficiencia ventilatoria (especialmente evidente en la variable VE/VCO2), producida a su vez por mecanismos adaptativos periféricos de ajuste bioquímico que afectan el patrón ventilatorio de los pacientes post COVID-19
dc.description.abstractenglishThis is a compilation of studies published in the scientific literature that describe the pathophysiology of COVID-19, the impact of the cardiopulmonary condition typical of this disease on cardiorespiratory fitness and exercise capacity in this group of patients and a detailed description of the holistic and integrative evaluation that the cardiopulmonary exercise test can provide of the cardiopulmonary function of patients recovered from SARS-CoV-2 infection, denoting the expected or most frequent findings in the tests performed in this population. We highlight that, even in patients who had mild COVID-19, cardiorespiratory function expressed in its flagship variable: oxygen uptake (VO2), is generally reduced, although this reduction is usually greater in the more severe cases. It has also been shown that this reduction can be influenced by ventilatory inefficiency (especially evident in the VE/VCO2 variable), produced in turn by peripheral adaptive mechanisms of biochemical adjustment that affect the ventilatory pattern of post-COVID-19 patients.
dc.description.degreelevelEspecializaciónspa
dc.description.degreenameEspecialista en Medicina del Deportespa
dc.description.sponsorshipIPS Bodytech
dc.format.mimetypeapplication/pdf
dc.identifier.instnameinstname:Universidad El Bosquespa
dc.identifier.reponamereponame:Repositorio Institucional Universidad El Bosquespa
dc.identifier.repourlrepourl:https://repositorio.unbosque.edu.co
dc.identifier.urihttps://hdl.handle.net/20.500.12495/12063
dc.language.isoes
dc.publisher.facultyFacultad de Medicinaspa
dc.publisher.grantorUniversidad El Bosquespa
dc.publisher.programEspecialización en Medicina del Deportespa
dc.relation.references1. Alpdagtas S, Ilhan E, Uysal E, Sengor M, Ustundag CB, Gunduz O. Evaluation of current diagnostic methods for COVID-19. APL Bioeng. 2020;4(4).
dc.relation.references2. Coronavirus disease (COVID-19) [Internet]. [cited 2022 May 30]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019?adgroupsurvey=%7Badgroupsurvey%7D&gclid=Cj0KCQjw1tGUBhDXARIsAIJx01mTANHWybVyDWc62STOcodD134vRI8uE7v-VNZY3WUo2FazpcRIVt0aAsbNEALw_wcB
dc.relation.references3. Coronavirus Colombia [Internet]. 2022 [cited 2022 May 30]. Available from: https://www.ins.gov.co/Noticias/paginas/coronavirus.aspx
dc.relation.references4. Salman D, Vishnubala D, Le Feuvre P, Beaney T, Korgaonkar J, Majeed A, et al. Returning to physical activity after covid-19. BMJ. 2021;372:1–6.
dc.relation.references5. Butt JH, Fosbøl EL, Gerds TA, Andersson C, Kragholm K, Biering-sørensen T, et al. All-causemortality and location of death in patients with established cardiovascular disease before, during, and after the COVID-19 lockdown: a Danish Nationwide Cohort Study. Eur Heart J. 2021;2019:1–9.
dc.relation.references6. Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA - J Am Med Assoc. 2020;324(8):782–93.
dc.relation.references7. Saavedra Trujillo C., Estrada Orozco K. SCA. Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-CoV-2/COVID-19 en establecimientos de atención de la salud. Rev la Asoc Colomb infectología. 2021;25(4).
dc.relation.references8. Gupta A, Madhavan M V., Sehgal K, Nair N, Mahajan S, Sehrawat TS, et al. Extrapulmonary manifestations of COVID-19. Nat Med [Internet]. 2020;26(7):1017–32. Available from: http://dx.doi.org/10.1038/s41591-020-0968-3
dc.relation.references9. Pascarella G, Strumia A, Piliego C, Bruno F, Del Buono R, Costa F, et al. COVID-19 diagnosis and management: a comprehensive review. J Intern Med. 2020;288(2):192–206.
dc.relation.references10. Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis [Internet]. 2020;20(4):425–34. Available from: http://dx.doi.org/10.1016/S1473-3099(20)30086-4
dc.relation.references11. Ministerio de Salud y Proteccion Social. Lineamientos para la evaluacion del riesgo y el tratamiento domiciliario, segun la valoracion medica asi lo determine, en pacientes con sospecha o confirmacion de infeccion por SARS-CoV-2 / COVID-19. 2020;1–20.
dc.relation.references12. Wu Z, McGoogan JM. Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases from the Chinese Center for Disease Control and Prevention. JAMA - J Am Med Assoc. 2020;323(13):1239–42.
dc.relation.references13. Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature [Internet]. 2021;594(7862):259–64. Available from: http://dx.doi.org/10.1038/s41586-021-03553-9
dc.relation.references14. Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet [Internet]. 2021;397(10270):220–32. Available from: http://dx.doi.org/10.1016/S0140-6736(20)32656-8
dc.relation.references15. Moulson N, Gustus SK, Scirica C, Petek BJ, Vanatta C, Churchill TW, et al. Diagnostic evaluation and cardiopulmonary exercise test findings in young athletes with persistent symptoms following COVID-19. Br J Sports Med. 2022;bjsports-2021-105157.
dc.relation.references16. Lemes IR, Smaira FI, Ribeiro WJD, Favero NK, Matos LDNJ, Pinto ALDS, et al. Acute and post-acute COVID-19 presentations in athletes: a systematic review and meta-analysis. Br J Sports Med. 2022;56(16):941–7.
dc.relation.references17. Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. J Adv Res [Internet]. 2020;24(April):91–8. Available from: https://doi.org/10.1016/j.jare.2020.03.005
dc.relation.references18. M. Cascella; M Rajnik; A. Cuomo et al. Features, Evaluation, and Treatment of Coronavirus - StatPearls - NCBI Bookshelf [Internet]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554776/
dc.relation.references19. Dhont S, Derom E, Van Braeckel E, Depuydt P, Lambrecht BN. Conceptions of the pathophysiology of happy hypoxemia in COVID-19. Respir Res. 2021;22(1):1–9.
dc.relation.references20. Antônio J, Teixeira C, Teixeira MF, Teixeira PS, Jorge JG. The Athlete ’ s Return in the Post-COVID-19. 2021;34(5):575–81.
dc.relation.references21. Laganà N, Cei M, Evangelista I, Cerutti S, Colombo A, Conte L, et al. Suspected myocarditis in patients with COVID-19: A multicenter case series. Medicine (Baltimore). 2021;100(8):e24552.
dc.relation.references22. Cremer P, Johri AM, Ms C, Emery MS, Sengupta PP. Screening of Potential Cardiac Involvement in Competitive Athletes Recovering From COVID-19. JACC Cardiovasc Imaging. 2020;13(12):2 6 3 5 – 5 2.
dc.relation.references23. Morley JE, Kalantar-Zadeh K, Anker SD. COVID-19: a major cause of cachexia and sarcopenia? J Cachexia Sarcopenia Muscle. 2020;11(4):863–5.
dc.relation.references24. Amatriain-Fernández S, Gronwald T, Murillo-Rodríguez E, Imperatori C, Solano AF, Latini A, et al. Physical Exercise Potentials Against Viral Diseases Like COVID-19 in the Elderly. Front Med. 2020;7(July):1–5.
dc.relation.references25. Miles MP, Wilson S, Yeoman CJ. Physical Activity and Inflammation Phenotype Conversion. J Clin Exerc Physiol. 2019;8(2):64–73.
dc.relation.references26. Wadley. A., Lucas. S. JB. Physical activity, exercise, and immune function. Brain Behav Immun. 2020;19(5):369–70.
dc.relation.references27. Schraufnagel DE, Agostoni P. Cardiopulmonary exercise testing. Ann Am Thorac Soc. 2017;14:S1–2.
dc.relation.references28. Weisman IM, Weisman IM, Marciniuk D, Martinez FJ, Sciurba F, Sue D, et al. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;167(2):211–77.
dc.relation.references29. Clavario P, De Marzo V, Lotti R, Barbara C, Porcile A, Russo C, et al. Assessment of functional capacity with cardiopulmonary exercise testing in non-severe COVID-19 patients at three months follow-up. ERJ Open Res. 2020;7(3):e1.
dc.relation.references30. Piero Clavario, Vincenzo De Marzo, Roberta Lotti CB, Annalisa Porcile, Carmelo Russo Federica Beccaria, Marco Bonavia LCB, Marta Caltabellotta, Flavia Chioni, Monica Santangel, Arto J. Hautala RG, Gianfranco Parati f, Ugo Corr`a IP. Cardiopulmonary exercise testing in COVID-19 patients at 3 months. Int J Cardiol. 2021;340,(January):113–118.
dc.relation.references31. Singh I, Joseph P, Heerdt PM, Cullinan M, Lutchmansingh DD, Gulati M, et al. Persistent Exertional Intolerance After COVID-19: Insights From Invasive Cardiopulmonary Exercise Testing. Chest. 2022;161(1):54–63.
dc.relation.references32. Raman B, Cassar MP, Tunnicliffe EM, Filippini N, Griffanti L, Alfaro-Almagro F, et al. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine. 2021;31.
dc.relation.references33. Skjørten I, Ankerstjerne OAW, Trebinjac D, Brønstad E, Rasch-Halvorsen Ø, Einvik G, et al. Cardiopulmonary exercise capacity and limitations 3 months after COVID-19 hospitalisation. Eur Respir J [Internet]. 2021;58(2):1–10. Available from: http://dx.doi.org/10.1183/13993003.00996-2021
dc.relation.references34. G D Back, M R Oliveira, P F Camargo, C L Goulart, C R Oliveira, K W Wende J C Bonjorno Junior, R F Arbex, F R Caruso, R Arena AB-S. Mild-to-moderate COVID19 impact on the cardiorespiratory fitness in young and middle aged populations back et al.pdf. Brazilian journal of medical and biological research;
dc.relation.references35. Gao Y, Chen R, Geng Q, Mo X, Zhan C, Jian W, et al. Cardiopulmonary exercise testing might be helpful for interpretation of impaired pulmonary function in recovered COVID-19 patients. Eur Respir J. 2021;57(1).
dc.relation.references36. Vonbank K, Lehmann A, Bernitzky D, Gysan MR, Simon S, Schrott A, et al. Predictors of Prolonged Cardiopulmonary Exercise Impairment After COVID-19 Infection: A Prospective Observational Study. Front Med. 2021;8(December):1–9.
dc.relation.references37. Debeaumont D, Boujibar F, Ferrand-Devouge E, Artaud-Macari E, Tamion F, Gravier FE, et al. Cardiopulmonary Exercise Testing to Assess Persistent Symptoms at 6 Months in People With COVID-19 Who Survived Hospitalization: A Pilot Study. Phys Ther. 2021;101(6):1–9.
dc.relation.references38. Baratto C, Caravita S, Faini A, Perego GB, Senni M, Badano LP, et al. Impact of COVID-19 on exercise pathophysiology: A combined cardiopulmonary and echocardiographic exercise study. J Appl Physiol. 2021;130(5):1470–8.
dc.relation.references39. Barbagelata L, Masson W, Iglesias D, Lillo E, Francisco J, Laura M, et al. Cardiopulmonary exercise testing in patients with Post-COVID-19 syndrome. Med Clin. 2021;(xxxx).
dc.relation.references40. Blokland IJ, Ilbrink S, Houdijk H, Dijkstra JW, van Bennekom CAM, Fickert R, et al. Inspanningscapaciteit na beademing vanwege covid-19. Ned Tijdschr Geneeskd. 2020;164:1–7.
dc.relation.references41. Balady GJ, Arena R, Sietsema K, Myers J, Coke L, Fletcher GF, et al. Clinician’s guide to cardiopulmonary exercise testing in adults: A scientific statement from the American heart association. Circulation. 2010;122(2):191–225.
dc.relation.references42. Pavy B, Iliou MC, Vergès-Patois B, Brion R, Monpère C, Carré F, et al. French Society of Cardiology guidelines for cardiac rehabilitation in adults. Arch Cardiovasc Dis. 2012;105(5):309–28.
dc.relation.references43. Arena R, Faghy MA. Cardiopulmonary exercise testing as a vital sign in patients recovering from COVID-19. Expert Rev Cardiovasc Ther [Internet]. 2021;19(10):877–80. Available from: https://doi.org/10.1080/14779072.2021.1985466
dc.relation.references44. Casos confirmados de COVID-19 | SALUDATA [Internet]. [cited 2022 Jun 16]. Available from: https://saludata.saludcapital.gov.co/osb/index.php/datos-de-salud/enfermedades-trasmisibles/covid19/
dc.relation.references45. Restrepo J, Palacios D, Espinal J. Gasto en salud durante la pandemia por covid-19 en países de América Latina. Grup Econ la Salud. 2022;
dc.relation.references46. Ferrazza AM, Martolini D, Valli G, Palange P. Cardiopulmonary exercise testing in the functional and prognostic evaluation of patients with pulmonary diseases. Respiration. 2009;77(1):3–17.
dc.relation.references47. Riebe D., Ehrman J., Liguori G. MM. ACSM’s Guidelines for exercise testing and prescription. Vol. 10, American College of Sports Medicine. 2018. 1689–1699 p.
dc.rightsAttribution 4.0 Internationalen
dc.rights.accessrightshttps://purl.org/coar/access_right/c_abf2
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.rights.localAcceso abiertospa
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectCardiopulmonary exercise testing
dc.subjectCOVID-19
dc.subjectSARS-CoV-2
dc.subjectCardiorrespiratory fitness
dc.subjectfunctional capacity
dc.subject.nlmQT 261
dc.titleDescripción de las características en prueba de esfuerzo cardiopulmonar en aptitud cardiorrespiratoria y respuesta al ejercicio de pacientes que cursaron con infección por SARS-CoV-2 leve
dc.title.translatedDescription of the characteristics of cardiopulmonary exercise testing in cardiorespiratory fitness and response to exercise in patients with mild SARS-CoV-2 infection
dc.type.coarhttps://purl.org/coar/resource_type/c_7a1f
dc.type.coarversionhttps://purl.org/coar/version/c_ab4af688f83e57aa
dc.type.driverinfo:eu-repo/semantics/bachelorThesis
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersion
dc.type.localTesis/Trabajo de grado - Monografía - Especializaciónspa

Archivos